Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredient
Jeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-si, Gyeonggi-do acquired approval from the European Directorate for the Quality of Medicines(EDQM).
The company had car...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
